- Home
- KALA vs GCTK Comparison
KALA vs GCTK Comparison
Compare KALA & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- GCTK
- Stock Information
- Founded
- KALA 2009
- GCTK 2001
- Country
- KALA United States
- GCTK United States
- Employees
- KALA N/A
- GCTK N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- GCTK Medical/Dental Instruments
- Sector
- KALA Health Care
- GCTK Health Care
- Exchange
- KALA Nasdaq
- GCTK Nasdaq
- Market Cap
- KALA 5.1M
- GCTK 5.9M
- IPO Year
- KALA 2017
- GCTK N/A
- Fundamental
- Price
- KALA $0.66
- GCTK $5.02
- Analyst Decision
- KALA Buy
- GCTK
- Analyst Count
- KALA 3
- GCTK 0
- Target Price
- KALA $31.50
- GCTK N/A
- AVG Volume (30 Days)
- KALA 244.4K
- GCTK 34.6K
- Earning Date
- KALA 11-07-2025
- GCTK 11-13-2025
- Dividend Yield
- KALA N/A
- GCTK N/A
- EPS Growth
- KALA N/A
- GCTK N/A
- EPS
- KALA N/A
- GCTK N/A
- Revenue
- KALA N/A
- GCTK N/A
- Revenue This Year
- KALA N/A
- GCTK N/A
- Revenue Next Year
- KALA N/A
- GCTK N/A
- P/E Ratio
- KALA N/A
- GCTK N/A
- Revenue Growth
- KALA N/A
- GCTK N/A
- 52 Week Low
- KALA $0.64
- GCTK $4.22
- 52 Week High
- KALA $20.60
- GCTK $468.00
- Technical
- Relative Strength Index (RSI)
- KALA 27.23
- GCTK 34.46
- Support Level
- KALA $0.64
- GCTK $5.39
- Resistance Level
- KALA $0.73
- GCTK $6.04
- Average True Range (ATR)
- KALA 0.06
- GCTK 0.27
- MACD
- KALA 0.32
- GCTK -0.11
- Stochastic Oscillator
- KALA 31.24
- GCTK 4.21
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.